Inventor · disambiguated record
Steen Jensen
Also filed as: JENSEN STEEN · JENSEN STEEN LINDKAER
8 granted patents·4 pending applications·546 citations·filing 1988–2024
89Inventor score
Files withASCENDIS PHARMA ENDOCRINOLOGY DIV A/S5NOVO NORDISK AS4IM RANDERS AS1JENSEN STEEN LINDKAER1RASMUSSEN LARS BOLDT1
Top patents by PatentIndex Score
12 records- 0194US5898028AMethod for producing powder formulation comprising an insulinNOVO NORDISK AS·Filed 1998·Granted Apr 27, 1999·230 cites·20 claims
- 0291US5948751AX14-mannitolNOVO NORDISK AS·Filed 1997·Granted Sep 7, 1999·126 cites·59 claims
- 0390US12133883B2Polymeric hGH prodrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2020·Granted Nov 5, 2024·2 cites·21 claims
- 0490US6043214AMethod for producing powder formulation comprising an insulinNOVO NORDISK AS·Filed 1998·Granted Mar 28, 2000·127 cites·31 claims
- 0589US10799563B2Polymeric hGH prodrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2015·Granted Oct 13, 2020·10 cites·21 claims
- 0686US2025032587A1Novel Polymeric hGH ProdrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2024·Application pending·0 cites
- 0782USD316923SLong underwear ensembleIM RANDERS AS·Filed 1988·Granted May 21, 1991·27 cites·1 claims
- 0871US2024366730A1Long-Acting Growth Hormone TreatmentASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2024·Application pending·0 cites
- 0964US6127334AMethods for producing biphasic insulin formulationsNOVO NORDISK AS·Filed 1998·Granted Oct 3, 2000·24 cites·23 claims
- 1045US12016903B2Long-acting growth hormone treatmentASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2015·Granted Jun 25, 2024·0 cites·20 claims
- 1141US2009041724A1Protein Delivery SystemJENSEN STEEN LINDKAER·Filed 2005·Application pending·0 cites
- 1239US2016017559A1Floating barrierRASMUSSEN LARS BOLDT·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steen Jensen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →